Grifols - comment

Grifols has applied to the German Federal Financial Supervisory Authority to squeeze out the minority shareholders in its Biotest subsidiary. Grifols owns 98% of the Ordinary shares and 43% of the Preference Shares after the acquisition in 2022. Grifols intends to make an offer for the outstanding shares as part of its plans to delist Biotest. This is expected and will simplify the Grifols capital structure.